Wedge liver resection as part of cytoreductive surgery in advanced ovarian cancer – a safe and feasible procedure for a gynecologic oncologist

Q4 Medicine
B. Banaś, P. Kołodziejczyk, K. Pityński, Michał Mleko, P. Richter
{"title":"Wedge liver resection as part of cytoreductive surgery in advanced ovarian cancer – a safe and feasible procedure for a gynecologic oncologist","authors":"B. Banaś, P. Kołodziejczyk, K. Pityński, Michał Mleko, P. Richter","doi":"10.15557/cgo.2021.0006","DOIUrl":null,"url":null,"abstract":"Objective: In this study, we aimed to determine the learning curve for liver wedge resection performed as part of cytoreductive surgery in advanced ovarian malignant tumors. Materials and methods: This was a retrospective analysis of 120 women diagnosed with stage IIIC ovarian cancer according to the International Federation of Gynecology and Obstetrics (FIGO) classification: 22 underwent liver wedge resection as part of cytoreductive surgery (Group A), while 98 did not require liver surgery (Group B). In the study, the t-Student test was used for variables with normal distribution and the Mann−Whitney U test was utilized for increment and abnormally distributed variables. The variables categorized were shown as a number of cases (n) and a percentage (%), and compared using the chi-square test, with a p-value <0.05 considered significant. A cumulative sum control chart (CUSUM) method was used to investigate the learning curves in both groups and the entire cohort. Results: There were no significant differences in the operating time, intraoperative blood loss, postoperative hospitalization or minor and severe adverse effects between the Groups A and B. The operative time, total blood loss, and incidence of adverse effects showed a similar learning curve for Group B and the entire cohort. Conclusion: It is safe and feasible for gynecologic oncologists to perform wedge liver resections as part of cytoreductive surgery in women with advanced ovarian tumors.","PeriodicalId":38739,"journal":{"name":"Current Gynecologic Oncology","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Gynecologic Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15557/cgo.2021.0006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: In this study, we aimed to determine the learning curve for liver wedge resection performed as part of cytoreductive surgery in advanced ovarian malignant tumors. Materials and methods: This was a retrospective analysis of 120 women diagnosed with stage IIIC ovarian cancer according to the International Federation of Gynecology and Obstetrics (FIGO) classification: 22 underwent liver wedge resection as part of cytoreductive surgery (Group A), while 98 did not require liver surgery (Group B). In the study, the t-Student test was used for variables with normal distribution and the Mann−Whitney U test was utilized for increment and abnormally distributed variables. The variables categorized were shown as a number of cases (n) and a percentage (%), and compared using the chi-square test, with a p-value <0.05 considered significant. A cumulative sum control chart (CUSUM) method was used to investigate the learning curves in both groups and the entire cohort. Results: There were no significant differences in the operating time, intraoperative blood loss, postoperative hospitalization or minor and severe adverse effects between the Groups A and B. The operative time, total blood loss, and incidence of adverse effects showed a similar learning curve for Group B and the entire cohort. Conclusion: It is safe and feasible for gynecologic oncologists to perform wedge liver resections as part of cytoreductive surgery in women with advanced ovarian tumors.
楔形肝切除术作为晚期卵巢癌细胞减少手术的一部分-对妇科肿瘤学家来说是一种安全可行的手术
目的:在本研究中,我们旨在确定作为晚期卵巢恶性肿瘤细胞减少手术一部分的肝楔形切除术的学习曲线。材料与方法:本研究回顾性分析120例IIIC期卵巢癌患者,根据国际妇产科学联合会(FIGO)分级:22例行肝楔切除作为减细胞手术的一部分(A组),98例不需要肝手术(B组)。本研究中,正态分布变量采用t-Student检验,增量和异常分布变量采用Mann - Whitney U检验。分类的变量显示为病例数(n)和百分比(%),并使用卡方检验进行比较,p值<0.05认为显著。采用累积和控制图(CUSUM)方法调查两组及整个队列的学习曲线。结果:A组与B组在手术时间、术中出血量、术后住院时间、轻、重度不良反应等方面均无显著差异。B组与整个队列的手术时间、总出血量、不良反应发生率的学习曲线相似。结论:妇科肿瘤学家在晚期卵巢肿瘤患者行楔形肝切除术是安全可行的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Gynecologic Oncology
Current Gynecologic Oncology Medicine-Obstetrics and Gynecology
自引率
0.00%
发文量
7
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信